Inferior Meatus Augmentation Procedure to Treat Empty Nose S
Inferior meatus augmentation procedure (IMAP) is effective in empty nose syndrome (ENS), finds a study published in The Laryngoscope.

Researchers sought to report the long-term, symptom-focused, prospective outcomes in empty nose syndrome (ENS) patients after undergoing inferior meatus augmentation procedure (IMAP) through the use of four validated questionnaires: Empty Nose Syndrome 6?Item Questionnaire (ENS6Q), 22-item Sino-Nasal Outcome Test (SNOT-22), Generalized Anxiety Disorder 7-Item Scale (GAD-7), and Patient Health Questionnaire-9 (PHQ-9).

A single-center prospective case series was performed on 17 patients diagnosed with ENS who underwent IMAP. Diagnosis of ENS was based on the following criteria: 1) reported discomfort with nasal breathing and/or paradoxical nasal obstruction after inferior turbinate reduction, 2) a positive ENS6Q score of at least 11, and 3) a positive cotton test. Questionnaire responses were recorded prior to surgery as well as 1, 3, 6, and 12-months postoperatively.

--Mean ENS6Q scores were significantly reduced at all postoperative time points.

--Of the six ENS6Q subdomains, five (suffocation, dryness, sense of diminished airflow, nasal crusting, and nasal burning) were significantly reduced 1-year postoperatively.

--SNOT-22 scores were significantly reduced at all time points. Of the SNOT-22 subdomains, the sleep subdomain was significantly reduced 1-year postoperatively.

--Low baseline GAD-7 and PHQ-9 scores were recorded at 7 and 9.4, respectively, and although scores at all postoperative time points were reduced, there was no statistical significance.

In summary, IMAP via implant of cadaveric rib cartilage provides significant, long-term improvements in ENS-specific and general sinonasal symptoms.